Oral cancer: Current and future diagnostic techniques

American Journal of Dentistry

Volumn 21, Issue 4, 2008, Pages 199-209

  Scully, Crispian ^a   Bagan, José V ^b   Hopper, Colin ^a   Epstein, Joel B ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; TUMOR MARKER;

BIOPSY; DENTISTRY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HUMAN; MASS SCREENING; METHODOLOGY; MOUTH TUMOR; PATIENT REFERRAL; PRECANCER; REVIEW;

BIOPSY; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; HUMANS; MASS SCREENING; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; REFERRAL AND CONSULTATION; SPECIALTIES, DENTAL; TUMOR MARKERS, BIOLOGICAL;

EID: 52049115657     PISSN: 08948275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (143)

1. Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias. Cancer 1975;36:1386-1392.
2. Wright JM. Oral precancerous lesions and conditions. Semin Dermatol 1994;13:125-131.
3. Sankaranarayanan R. Screening for cervical and oral cancers in India is feasible and effective. Natl Med J India 2005;18:281-284.
4. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, Rajan B. Trivandrum oral cancer screening study group. Effect of screening on oral cancer mortality in Kerala, India: A cluster-randomised controlled trial. Lancet 2005 Jun 4-10;365(9475):1927-1933.
5. Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: Review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol 2006;102:67-76.
6. Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med 1995;6:147-160.
7. Scully C, Cawson R. Potentially malignant oral lesions. J Epidemiol Biostat 1996;1:3-12.
8. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 1995;45:328-351.
9. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6:963-968.
10. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res 2003;63:1727-1730.
11. Braakhuis BJ, Leemans CR, Brakenhoff RH. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 2005;15:113-120.
12. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ. Genetically altered fields as origin of locally recurrent head and neck cancer: A retrospective study. Clin Cancer Res 2004; 10:3607-3613.
13. Thomson PJ. Field change and oral cancer: New evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg 2002;31:262-266.
14. Thomson PJ, Hamadah O. Cancerisation within the oral cavity: The use of "field mapping biopsies" in clinical management. Oral Oncol 2007;43:20-26.
15. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989;17:691-694.
16. Sankaranarayanan R, Fernandez GL, Lence AJ, Pisani P, Rodriguez SA. Visual inspection in oral cancer screening in Cuba: A case-control study. Oral Oncol 2002;38:131-136.
17. Shugars DC, Patton LL. Detecting, diagnosing, and preventing oral cancer. Nurse Pract 1997;22:105,109-10,113-115.
18. Downer MC, Moles DR, Palmer S, Speight PM. A systematic review of measures of effectiveness in screening for oral cancer and precancer. Oral Oncol 2006;42:551-560.
19. Kujan O, Glenny AM, Sloan P. Screening for oral cancer. Lancet 2005 Oct 8;366(9493):1265-1266; author reply 1266.
20. Kujan O, Glenny AM, Oliver RJ, Thakker N, Sloan P. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev 2006;3:CD004150.
21. Silverman S Jr. Early diagnosis of oral cancer. Cancer 1988;62:1796-1799.
22. Mashberg A, Merletti F, Boffetta P, Gandolfo S, Ozzello F, Fracchia F, Terracini B. Appearance, site of occurrence, and physical and clinical characteristics of oral carcinoma in Torino, Italy. Cancer 1989;63:2522-2527.
23. Mashberg A, Feldman LJ. Clinical criteria for identifying early oral and oropharyngeal carcinoma: Erythroplasia revisited. Am J Surg 1988; 156:273-275.
24. Scully C, Malamos D, Levers BG, Porter SR, Prime SS. Sources and patterns of referrals of oral cancer: Role of general practitioners. Br Med J (Clin Res Ed) 1986;293:599-601.
25. Dimitroulis G, Reade P, Wiesenfeld D. Referral patterns of patients with oral squamous cell carcinoma, Australia. Eur J Cancer B Oral Oncol 1992;28B:23-27.
26. Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol 1986;61:373-381.
27. Silverman S. Oral cancer. Semin Dermatol 1994;13:132-137.
28. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol 1995;79:321-329.
29. Woolgar J. A pathologist's view of oral cancer in the North West. Br Dent J 1995;54:14-16.
30. Sciubba JJ. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol 2001;2:239-251.
31. US Preventive Services Task Force. Guide to clinical preventive services. 1996. Baltimore, Williams and Wilkins.
32. Burzynski NJ, Firriolo FJ, Butters JM, Sorrell CL. Evaluation of oral cancer screening. J Cancer Educ 1997;12:95-99.
33. Bouquot JE. Common oral lesions found during a mass screening examination. J Am Dent Assoc 1986;112:50-57.
34. Malaovalla AM, Silverman S, Mani NJ, Bilimoria KF, Smith LW. Oral cancer in 57,518 industrial workers of Gujarat, India: A prevalence and followup study. Cancer 1976;37:1882-1886.
35. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2006;42:229-239.
36. 2 laser on an out-patient basis: A useful procedure for prevention and early detection of oral carcinomas. Tumori 1986;72:307-312.
37. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 2000;6:347-352.
38. Braakhuis BJ, Leemans CR, Brakenhoff RH. A genetic progression model of oral cancer: Current evidence and clinical implications. J Oral Pathol Med 2004;33:317-322.
39. Abbey LM, Kaugars GE, Gunsolley JC, Burns JC, Page DG, Svirsky JA, Eisenberg E, Krutchkoff DJ, Gushing M. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol 1995;80:188-191.
40. Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 1995;24:198-200.
41. Fischer DJ, Epstein JB, Morton TH, Schwartz SM. Interobserver reliability in the histopathologic diagnosis of oral premalignant and malignant lesions. J Oral Pathol Med 2004;33:65-70.
42. Fischer DJ, Epstein JB, Morton TH, Schwartz SM. Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients. Oral Oncol 2005;41:489-496.
43. Mehrotra R, Gupta A, Singh M, Ibrahim R. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer 2006 Mar 23;5:11.
44. Epstein JB, Feldman R, Dolor RJ, Porter SR. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 2003; 25:911-921.
45. Gandolfo S, Pentenero M, Broccoletti R, Pagano M, Carrozzo M, Scully C. Toluidine blue uptake in potentially malignant oral lesions in vivo: Clinical and histological assessment. Oral Oncol 2006;42:89-95.
46. Mashberg A. Reevaluation of Toluidine Blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma. Cancer 1980;46:754-763.
47. Rosenberg D, Cretin S. Use of meta analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol 1989;67:621-627.
48. Zhang L, Williams M, Poh CF, Laronde D, Epstein J, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005;65:8017-8021.
49. Guo Z, Yamaguchi K, Sanchez-Cespedes M, Westra WH, Koch WM, Sidransky D. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Clin Cancer Res 2001;7:1963-1968.
50. Silverman S Jr, Migliorati C, Barbosa J. Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Med Oral Pathol 1984;57:379-382.
51. Missmann M, Jank S, Laimer K, Gassner R. A reason for the use of toluidine blue staining in the presurgical management of patients with oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol 2006;102:741-473.
52. Scully C, Sudbo J, Speight PM. Progress in determining the malignant potential of oral lesions. J Oral Pathol Med 2003;32:251-256.
53. Derka S, Vairaktaris E, Papakosta V, Vassiliou S, Acil Y, Vylliotis A, Spyridonidou S, Lazaris AC, Mourouzis C, Kokkori A, Moulavasili P, Perrea D, Donta I, Yapijakis C, Patsouris E. Cell proliferation and apoptosis culminate in early stages of oral oncogenesis. Oral Oncol 2006;42:540-550.
54. Diniz-Freitas M, Garcia-Caballero T, Antunez-Lopez J, Gandara-Rey JM, Garcia-Garcia A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 2006;42:190-200.
55. Hamidi S, Salo T, Kainulainen T, Epstein J, Lerner K, Larjava H. Expression of alfa(v)beta6 integrin in oral leukoplakia. Br J Cancer 2000;82:1433-1440.
56. Kuratomi Y, Kumamoto M, Kidera K, Toh S, Masuda M, Nakashima T, Inokuchi A. Diffuse expression of laminin gamma 2 chain in disseminating and infiltrating cancer cells indicates a highly malignant state in advanced tongue cancer. Oral Oncol 2006;42:73-76.
57. Mathe M, Suba Z, Nemeth Z, Tatrai P, Fule T, Borgulya G, Barabas J, Kovalszky I. Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas. Oral Oncol 2006;42:493-500.
58. Pektas ZO, Keskin A, Gunhan O, Karslioglu Y. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: Quantitative cytologic assessment and review of methods for cytomorphometric measurements. J Oral Maxillofac Surg 2006;64:628-635.
59. Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OtalCDx Study Group. J Am Dent Assoc 1999;130:1445-1457.
60. Christian DC. Computer-assisted analysis of oral brush biopsies at an oral cancer screening program. J Am Dent Assoc 2002;133:357-362.
61. Svirsky JA, Burns JC, Carpenter WM, Cohen DM, Bhattacharyya I, Fantasia JE, Lederman DA, Lynch DP, Sciubba JJ, Zunt SL. Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent 2002;50:500-503.
62. Poate TW, Buchanan JA, Hodgson TA, Speight PM, Barrett AW, Moles DR, Scully C, Porter SR. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol 2004;40:829-834.
63. Potter TJ, Summerlin DJ, Campbell JH. Oral malignancies associated with negative transepithelial brush biopsy. J Oral Maxillofac Surg 2003; 61:674-677.
64. Scheifele C, Schmidt-Westhausen AM, Dietrich T, Reichart PA. The sensitivity and specificity of the OralCDx technique: Evaluation of 103 cases. Oral Oncol 2004;40:824-828.
65. Rick GM. Oral brush biopsy: The problem of false positives. Oral Surg, Oral Med, Oral Pathol 2003;96; 252.
66. Scheifele C, Schlechte H, Bethke G, Reichart PA. Detection of TP53-mutations in brush biopsies from oral leukoplakias. Mund Kiefer Gesichtschir 2002;6:410-414. (In German).
67. Remmerbach TW, Mathes SN, Weidenbach H, Hemprich A, Bocking A. Noninvasive brush biopsy as an innovative tool for early detection of oral carcinomas. Mund Kiefer Gesichtschir 2004;8:229-236. (In German).
68. Maraki D, Becker J, Boecking A. Cytologic and DNA-cytometric very early diagnosis of oral cancer. J Oral Pathol Med 2004;33:398-404.
69. Remmerbach TW, Weidenbach H, Muller C, Hemprich A, Pomjanski N, Buckstegge B, Bocking A. Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity. Anal Cell Pathol 2003;25:139-146.
70. Remmerbach TW, Weidenbach H, Hemprich A, Bocking A. Earliest detection of oral cancer using non-invasive brush biopsy including DNA-image-cytometry: Report on four cases. Anal Cell Pathol 2003;25:157-158.
71. Swinson B, Jerjes W, El-Maaytah M, Norris P, Hopper C. Optical techniques in diagnosis of head and neck malignancy. Oral Oncol 2006; 42: 221-228.
72. Suhr MA, Hopper C, Jones L, George JG, Bown SG, MacRobert AJ. Optical biopsy systems for the diagnosis and monitoring of superficial cancer and precancer. Int J Oral Maxillofac Surg 2000;29:453457.
73. Huber MA, Bsoul SA, Terezhalmy GT. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: A pilot study. Quintessence Int 2004;35:378-384.
74. Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 2005;34:521-527.
75. Epstein JB, Gorsky M, Lonky S, Silverman S Jr, Epstein JD, Bride M. The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions. Spec Care Dentist 2006;26:171-174.
76. Farah CS, McCullough MJ. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLitetrade mark) in the visualisation of oral mucosal white lesions. Oral Oncol 2007; 43:820-824.
77. Kerr AR, Sirois DA, Epstein JB. Clinical evaluation of chemiluminescent lighting: An adjunct for oral mucosal examinations. J Clin Dent 2006;17:59-63.
78. Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg 2007;65:424-426.
79. Rosin MP, Poh CF, Guillard M, Williams PM, Zhang L, Macaulay C. Visualization and other emerging technologies as change makers for oral cancer prevention. Ann N Y Acad Sci 2007;1098:167-183.
80. Gillenwater A, Jacob R, Ganeshappa R, Kemp B, El-Naggar AK, Palmer JL, Clayman G, Mitchell MF, Richards-Kortum R. Noninvasive diagnosis of oral neoplasia based on fluorescence spectroscopy and native tissue autofluorescence. Arch Otolaryngol Head Neck Surg 1998;124:1251-1258.
81. Gillenwater A, Jacob R, Richards-Kortum R. Fluorescence spectroscopy: A technique with potential to improve the early detection of aerodigestive tract neoplasia. Head Neck 1998;20:556-562.
82. Schantz SP, Kolli V, Savage HE, Yu G, Shah JP, Harris DE, Katz A, Alfano RR, Huvos AG. In vivo native cellular fluorescence and histological characteristics of head and neck cancer. Clin Cancer Res 1998;4:1177-1182.
83. Heintzelman DL, Utzinger U, Fuchs H, Zuluaga A, Gossage K, Gillenwater AM, Jacob R, Kemp B, Richards-Kortum RR. Optimal excitation wavelengths for in vivo detection of oral neoplasia using fluorescence spectroscopy. Photochem Photobiol 2000;72:103-113.
84. Muller MG, Valdez TA, Georgakoudi I, Backman V, Fuentes C, Kabani S, Laver N, Wang Z, Boone CW, Dasari RR, Shapshay SM, Feld MS. Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma. Cancer 2003;97:1681-1692.
85. Ingrams DR, Dhingra JK, Roy K, Perrault DF Jr, Bottrill ID, Kabani S, Rebeiz EE, Pankratov MM, Shapshay SM, Manoharan R, Itzkan I, Feld MS. Autofluorescence characteristics of oral mucosa. Head Neck 1997;19:27-32.
86. Inaguma M, Hashimoto K. Porphyrin-like fluorescence in oral cancer: In vivo fluorescence spectral characterization of lesions by use of a near-ultraviolet excited autofluorescence diagnosis system and separation of fluorescent extracts by capillary electrophoresis. Cancer 1999;86:2201-2211.
87. Kulapaditharom B, Boonkitticharoen V. Performance characteristics of fluorescence endoscope in detection of head and neck cancers. Ann Otol Rhinol Laryngol 2001;110:45-52.
88. de Veld DC, Skurichina M, Witjes MJ, Duin RP, Sterenborg HJ, Roodenburg JL. Autofluorescence and diffuse reflectance spectroscopy for oral oncology. Lasers Surg Med 2005;36:356-364.
89. de Veld DC, Bakker Schut TC, Skurichina M, Witjes MJ, Van der Wal JE, Roodenburg JL, Sterenborg HJ. Autofluorescence and Raman microspectroscopy of tissue sections of oral lesions. Lasers Med Sci 2005;19:203-209.
90. de Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL. The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol 2005;41:117-131.
91. Svistun E, Alizadeh-Naderi R, El-Naggar A, Jacob R, Gillenwater A, Richards-Kortum R. Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence. Head Neck 2004;26:205-215.
92. Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, Williams PM, Zhang L, Rosin MP, MacAulay CE. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt 2006;11:024006.
93. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, Berean KW, Ng S, Tseng OL, MacAulay C, Rosin MP. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 2006;12:6716-6722.
94. Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, Macaulay C, Rosin MP. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck 2007;29:71-76.
95. Rosin MP, Epstein JB, Berean K, Durham S, Hay J, Cheng X, Zeng T, Huang Y, Zhang L. The use of exfoliative cell samples to map clonal genetic alterations in the oral epithelium of high-risk patients. Cancer Res 1997;57:5258-5260.
96. Spafford MF, Koch WM, Reed AL, Califano JA, Xu LH, Eisenberger CF, Yip L, Leong PL, Wu L, Liu SX, Jeronimo C, Westra WH, Sidransky D. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 2001;7:607-612.
97. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004;10:8442-8450.
98. Li Y, St John MA, Wong DT. RNA profiling of cell-free saliva using microarray technology. J Dent Res 2004;83:199-203.
99. Hu S, Li Y, Wang J, Xie Y, Tjon K, Wolinsky L, Loo RR, Loo JA, Wong DT. Human saliva proteome and transcriptome. J Dent Res 2006;85:1129-1133.
100. Hu S, Loo JA, Wong DT. Human saliva proteome analysis. Ann N Y Acad Sci 2007;1098:323-329.
101. Zimmermann BG, Park NJ, Wong DT. Genomic targets in saliva. Ann N Y Acad Sci 2007;1098:184-191.
102. Park NJ, Li Y, Yu T, Brinkman BM, Wong DT. Characterization of RNA in saliva. Clin Chem 2006;52;988-994.
103. 103.Park NJ, Zhou X, Yu T, Brinkman BM, Zimmermann BG, Palanisamy V, Wong DT. Characterization of salivary RNA by cDNA library analysis. Arch Oral Biol 2007;52:30-35.
104. Wong DT. Salivary diagnostics for oral cancer. J Calif Dent Assoc 2006;34:303-308.
105. Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, Jen J, Sidransky D. Promoter hypermethylation patterns of p16,06-methylguanine-DNA- methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001;61:939-942.
106. Juusola J, Ballantyne J. Messenger RNA profiling: A prototype method to supplant conventional methods for body fluid identification. Forensic Sci Int 2003;135:85-96.
107. Wang J, Henry S, Yu T, Li Y, Elashoff D, Oh M, Li K-C, Wei X, Wong D. Salivary oral cancer transcriptome biomarkers (SOCTB) for clinical detection. 2006, 35th Annual Meeting AADR; (Abstr 218).
108. Franzmann EJ, Weed DT, Civantos FJ, Goodwin WJ, Bourguignon LY. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression. Otolaryngol Head Neck Surg 2001;124:426-432.
109. Reategui EP, de Mayolo AA, Das PM, Astor FC, Singal R, Hamilton KL, Goodwin WJ, Carraway KL, Franzmann EJ. Characterization of CD44v3-containing isoforms in head and neck cancer. Cancer Biol Ther 2006;5:1163-1168.
110. Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ. Salivary soluble CD44: A potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev 2005;14:735-739.
111. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 2005;3: 27.
112. Dhingra JK, Zhang X, McMillan K, Kabani S, Manoharan R, Itzkan I, Feld MS, Shapshay SM. Diagnosis of head and neck precancerous lesions in an animal model using fluorescence spectroscopy. Laryngoscope 1998;108 (4 Pt 1): 471-475.
113. Wang CY, Tsai T, Chen HC, Chang SC, Chen CT, Chiang CP. Autofluorescence spectroscopy for in vivo diagnosis of DMBA-induced hamster buccal pouch pre-cancers and cancers. J Oral Pathol Med 2003;32:18-24.
114. Zheng W, Soo KC, Sivanandan R, Olivo M. Detection of neoplasms in the oral cavity by digitized endoscopic imaging of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Int J Oncol 2002;21:763-768.
115. Leunig A, Betz CS, Baumgartner R, Grevers G, Issing WJ. Initial experience in the treatment of oral leukoplakia with high-dose vitamin A and follow-up 5-aminolevulinic acid induced protoporphyrin IX fluorescence. Eur Arch Otorhinolaryngol 2000;257:327-331.
116. Leunig A, Betz CS, Heinrich P, Janda P, Baumgartner R. Fluorescence staining of oral and laryngeal cancer after application of 5-aminolevulinic acid. Laryngorhinootologie 2002;81:807-814. (In German).
117. Leunig A, Betz CS, Mehlmann M, Stepp H, Arbogast S, Grevers G, Baumgartner R. A pilot series demonstrating fluorescence staining of laryngeal papilloma using 5-aminolevulinic acid. Laryngoscope 2000; 110:1783-1785.
118. Leunig A, Betz CS, Mehlmann M, Stepp H, Arbogast S, Grevers G, Baumgartner R. Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Laryngoscope 2000;110:78-83.
119. Mehlmann M, Betz CS, Stepp H, Arbogast S, Baumgartner R, Grevers G, Leunig A. Fluorescence staining of laryngeal neoplasms after topical application of 5-aminolevulinic acid: Preliminary results. Lasers Surg Med 1999;25:414-420.
120. Jiang C, Wang C, Chiang C. Oral cancer detection in fluorescent image by color image fusion. Conf Proc IEEE Eng Med Biol Soc 2004;2:1260-1262.
121. Majumder SK, Ghosh N, Gupta PK. Relevance vector machine for optical diagnosis of cancer. Lasers Surg Med 2005;36:323-333.
122. Majumder SK, Ghosh N, Gupta PK. Support vector machine for optical diagnosis of cancer. J Biomed Opt 2005;10:024034.
123. Majumder SK, Ghosh N, Kataria S, Gupta PK. Nonlinear pattern recognition for laser-induced fluorescence diagnosis of cancer. Lasers Surg Med 2003;33:48-56.
124. Sharwani A, Jerjes W, Salih V, MacRobert AJ, El-Maaytah M, Khalil HS, Hopper C. Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy. J Photochem Photobiol B 2006;83:27-33.
125. Jerjes W, Swinson B, Johnson KS, Thomas GJ, Hopper C. Assessment of bony resection margins in oral cancer using elastic scattering spectroscopy: A study on archival material. Arch Oral Biol 2005;50:361-366.
126. Jerjes W, Swinson B, Pickard D, Thomas GJ, Hopper C. Detection of cervical intranodal metastasis in oral cancer using elastic scattering spectroscopy. Oral Oncol 2004;40:673-678.
127. Sharwani A, Jerjes W, Salih V, Swinson B, Bigio IJ, El-Maaytah M, Hopper C. Assessment of oral premalignancy using elastic scattering spectroscopy. Oral Oncol 2006;42:343-349.
128. Oliveira AP, Bitar RA, Silveira L, Zângaro RA, Martin AA. Near-infrared Raman spectroscopy for oral carcinoma diagnosis. Photomed Laser Surg 2006;24:348-353.
129. Cox BT, Arridge SR, Kostli KP, Beard PC. Two-dimensional quantitative photoacoustic image reconstruction of absorption distributions in scattering media by use of a simple iterative method. Appl Opt 2006;45:1866-1875.
130. Laufer J, Elwell C, Delpy D, Beard P. In vitro measurements of absolute blood oxygen saturation using pulsed near-infrared photoacoustic spectroscopy: Accuracy and resolution. Phys Med Biol 2005;50:4409-4428.
131. Beard PC. Two-dimensional ultrasound receive array using an angle-tuned Fabry-Perot polymer film sensor for transducer field characterization and transmission ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2005;52:1002-1012.
132. Kostli KP, Beard PC. Two-dimensional photoacoustic imaging by use of Fourier-transform image reconstruction and a detector with an anisotropic response. Appl Opt 2003;42:1899-1908
133. Brown E, McKee T, diTomaso E, Pluen A, Seed B, Boucher Y, Jain RK. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat Med 2003;9:796-800.
134. Lindeboom JA, Mathura KR, Ince C. Orthogonal polarization spectral (OPS) imaging and topographical characteristics of oral squamous cell carcinoma. Oral Oncol 2006;42:581-585.
135. Ridgway JM, Armstrong WB, Guo S, Mahmood U, Su J, Jackson RP, Shibuya T, Crumley RL, Gu M, Chen Z, Wong BJ. In vivo optical coherence tomography of the human oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 2006;132:1074-1081.
136. Wilder-Smith P, Jung WG, Brenner M, Osann K, Beydoun H, Messadi D, Chen Z. In vivo optical coherence tomography for the diagnosis of oral malignancy. Lasers Surg Med 2004;35:269-275.
137. Fitzgerald AJ, Wallace VP, Jimenez-Linan M, Bobrow L, Pye RJ, Purushotham AD, Arnone DD. Terahertz pulsed imaging of human breast tumors. Radiology 2006;239:533-540.
138. Pickwell E, Cole BE, Fitzgerald AJ, Pepper M, Wallace VP. In vivo study of human skin using pulsed terahertz radiation. Phys Med Biol 2004;49:1595-1607.
139. Pickwell E, Fitzgerald AJ, Cole BE, Taday PF, Pye RJ, Ha T, Pepper M, Wallace VP. Simulating the response of terahertz radiation to basal cell carcinoma using ex vivo spectroscopy measurements. J Biomed Opt 2005;10:064021.
140. Wallace VP, Fitzgerald AJ, Shankar S, Flanagan N, Pye R, Cluff J, Arnone DD. Terahertz pulsed imaging of basal cell carcinoma ex vivo and in vivo. Br J Dermatol 2004;151:424-432.
141. Wallace VP, Taday PF, Fitzgerald AJ, Woodward RM, Cluff J, Pye RJ, Arnone DD. Terahertz pulsed imaging and spectroscopy for biomedical and pharmaceutical applications. Faraday Discuss 2004;126:255-263; 303-311.
142. Woodward RM, Cole BE, Wallace VP, Pye RJ, Arnone DD, Linfield EH, Pepper M. Terahertz pulse imaging in reflection geometry of human skin cancer and skin tissue. Phys Med Biol 2002;47:3853-3863.
143. Woodward RM, Wallace VP, Pye RJ, Cole BE, Arnone DD, Linfield EH, Pepper M. Terahertz pulse imaging of ex vivo basal cell carcinoma. J Invest Dermatol 2003;120:72-78.